Evidence map›Paper›PMID 41479671›Full record

ArticleFrontiers in nutrition2025

CALLY index predicts survival and surgical outcomes in colorectal cancer.

Yunmeng Zong, Yulong Wang, Ying Chen, Xiao Feng, Bin Jiang, Yun Li

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunmeng ZongDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.
Yulong WangDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.
Ying ChenDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.
Xiao FengDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.
Bin JiangDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.
Yun LiDepartment of Gastrointestinal Surgery, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prognostic evaluation of colorectal cancer (CRC) traditionally relies on TNM staging, which fails to incorporate host-related factors such as systemic inflammation, nutrition, and immunity. The C-reactive protein-albumin-lymphocyte (CALLY) index has recently been proposed as a novel biomarker integrating these domains. Methods: We retrospectively analyzed 957 patients with CRC undergoing curative resection (2010-2020). The CALLY index was calculated from preoperative laboratory data. Patients were stratified into high- and low-CALLY groups using ROC-derived cutoffs. Associations with postoperative complications, overall survival (OS), and disease-free survival (DFS) were assessed and compared with other indices (mGPS, PNI, NLR, PLR, SII, CAR). Results: Low CALLY was significantly associated with higher complication rates (23.0% vs. 14.9%, Conclusion: The preoperative CALLY index is a simple, cost-effective, and reliable prognostic biomarker for CRC, predicting both surgical outcomes and long-term survival. Incorporation of CALLY into risk stratification may complement TNM staging, optimize perioperative management, and inform individualized treatment strategies. Further validation in multicenter, prospective cohorts is required to confirm the generalizability of these findings.

Indexed as

CALLY indexcolorectal cancerprognostic biomarkersurvival analysissystemic inflammation

Identifiers

PMID41479671
PMCPMC12753397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.